"Farmer PB" - Search Results

Year	Number of Results
1972	1
1973	4
1974	2
1975	3
1976	3
1977	4
1978	3
1979	2
1980	3
1981	4
1982	4
1983	5
1984	8
1985	1
1986	6
1987	10
1988	8
1989	5
1990	7
1991	6
1992	5
1993	4
1994	5
1995	3
1996	6
1997	6
1998	3
1999	6
2000	5
2001	2
2002	7
2003	3
2004	14
2005	16
2006	10
2007	27
2008	11
2009	14
2010	11
2011	11
2012	6
2013	4
2014	3
2015	2
2016	1
2018	1
2021	0

1

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P. Gallo V, et al. Eur J Clin Invest. 2012 Jan;42(1):1-16. doi: 10.1111/j.1365-2362.2011.02561.x. Epub 2011 Oct 25. Eur J Clin Invest. 2012. PMID: 22023344 Free article.

2

Benzene and non-Hodgkin's lymphoma.

O'Connor SR, Farmer PB, Lauder I. O'Connor SR, et al. J Pathol. 1999 Dec;189(4):448-53. doi: 10.1002/(SICI)1096-9896(199912)189:4<448::AID-PATH458>3.0.CO;2-K. J Pathol. 1999. PMID: 10629542 Review.

3

Phosphotriester adducts (PTEs): DNA's overlooked lesion.

Jones GD, Le Pla RC, Farmer PB. Jones GD, et al. Mutagenesis. 2010 Jan;25(1):3-16. doi: 10.1093/mutage/gep038. Epub 2009 Nov 17. Mutagenesis. 2010. PMID: 19920061 Review.

4

Innovative agents in cancer prevention.

Manson MM, Farmer PB, Gescher A, Steward WP. Manson MM, et al. Recent Results Cancer Res. 2005;166:257-75. doi: 10.1007/3-540-26980-0_17. Recent Results Cancer Res. 2005. PMID: 15648195 Review.

5

Metabolism and reactions of alkylating agents.

Farmer PB. Farmer PB. Pharmacol Ther. 1987;35(3):301-58. doi: 10.1016/0163-7258(87)90099-4. Pharmacol Ther. 1987. PMID: 3324117 Review. No abstract available.

6

Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrile.

Léonard A, Gerber GB, Stecca C, Rueff J, Borba H, Farmer PB, Sram RJ, Czeizel AE, Kalina I. Léonard A, et al. Mutat Res. 1999 May;436(3):263-83. doi: 10.1016/s1383-5742(99)00006-x. Mutat Res. 1999. PMID: 10354525 Review.

7

DNA adducts: mass spectrometry methods and future prospects.

Farmer PB, Brown K, Tompkins E, Emms VL, Jones DJ, Singh R, Phillips DH. Farmer PB, et al. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):293-301. doi: 10.1016/j.taap.2004.12.020. Toxicol Appl Pharmacol. 2005. PMID: 15990134 Review.

8

Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection.

Singh R, Farmer PB. Singh R, et al. Carcinogenesis. 2006 Feb;27(2):178-96. doi: 10.1093/carcin/bgi260. Epub 2005 Nov 4. Carcinogenesis. 2006. PMID: 16272169 Review.

9

Biological relevance of adduct detection to the chemoprevention of cancer.

Sharma RA, Farmer PB. Sharma RA, et al. Clin Cancer Res. 2004 Aug 1;10(15):4901-12. doi: 10.1158/1078-0432.CCR-04-0098. Clin Cancer Res. 2004. PMID: 15297390 Free article. Review.

10

An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.

Pottenger LH, Andrews LS, Bachman AN, Boogaard PJ, Cadet J, Embry MR, Farmer PB, Himmelstein MW, Jarabek AM, Martin EA, Mauthe RJ, Persaud R, Preston RJ, Schoeny R, Skare J, Swenberg JA, Williams GM, Zeiger E, Zhang F, Kim JH. Pottenger LH, et al. Crit Rev Toxicol. 2014 Apr;44(4):348-91. doi: 10.3109/10408444.2013.873768. Epub 2014 Feb 4. Crit Rev Toxicol. 2014. PMID: 24494825 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results